Senior Manager Regulatory Affairs - Digital Innovation Europe

Location: Berlin, Germany
Job Type: Full-Time
Employer: Amgen
For our innovative Tech Hub, based in the heart of Berlin, we are currently seeking a Senior Manager Regulatory Affairs - Digital Innovation Europe. The successful candidate will primarily provide device regulatory subject matter expertise in the assigned regional Tech Hubs and regulatory guidance for technologies that are of interest to Amgen.

Additional responsibilities

  • Responsible for providing the regulatory considerations and strategies for product prototype development, proof-of-concept activities, partnership options and vendor due diligence
  • Develop, implement, communicate, and maintain regional regulatory plans for TDI/DH (Technology Innovation/Digital Health) initiatives/ projects
  • Perform device determinations for TDI/DH programs as needed
  • Provide support with review of external communications with hospitals, clinics and academic innovation centers as well as contracts, terms and conditions from a regulatory perspective.
  • Support TDI/DH technology & software development (including co-development and supplier management) efforts by providing regulatory guidance
  • Deliver ongoing device education and training to TDI/DH colleagues pertaining to innovation
  • Assist in training Amgen Affiliates with respect to regulatory requirements of developing TDI/DH products
  • Facilitate communication of changes in Regulations, Standards, and Policy which are likely to impact TDI/DH activities
  • Represent the EU Tech Hub/Amgen at external events
  • Responsible for developing and maintaining an overall EU process map to bring digital products to market
  • Collaborate with Device Regulatory International personnel who perform EU based (legal manufacturer) registrations
  • Help identify responsible quality contact as needed for project specific needs as well as help identify responsible legal contact as needed

Minimum Reuirements

  • Doctorate degree and 2 years of relevant EU regulatory experience
  • or Master's degree and 4 years of relevant EU regulatory experience
  • or Bachelor's degree and 6 years of relevant EU regulatory experience

Preferred Qualifications

  • 5+ years experience in EU device regulatory matters
  • Some regulatory experience in drug regulatory matters
  • Multi-sectoral awareness/exposure a bonus
  • Regulatory Device and Design Control experience
  • Software development in the healthcare sector
  • Experience working in cross-functional matrix organization
  • Fluent in English

Apply for this job

About Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

Post your job offer now to start hiring the best digital health talent! For further information, please contact us.

Most Popular Now

Is Your Marketing Effective for an NHS C…

How can you make sure you get the right message across to an NHS chief information officer, or chief nursing information officer? Replay this webinar with Professor Natasha Phillips, former...

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

AI can Predict Study Results Better than…

Large language models, a type of AI that analyses text, can predict the results of proposed neuroscience studies more accurately than human experts, finds a new study led by UCL...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...